阿片类药物和肠道微生物群之间的双向关系:对阿片类药物耐受性和临床干预措施的影响
Zahra S Taboun1, Javad Sadeghi2
1Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
International immunopharmacology
|November 2, 2023
概括
随着长期使用,阿片类药物的耐受性和过量服用风险会增加. 肠道微生物群影响这种耐受性,表明微生物群调制是阿片类药物使用障碍的潜在治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 阿片类药物对于治疗疼痛至关重要,但与滥用,耐受性和致命的过量服用有关.
- 慢性阿片类药物使用导致耐受性,降低药物的疗效,增加过量服用的风险.
- 肠道微生物群在阿片类药物耐受性发展中发挥着重要作用.
研究的目的:
- 审查肠道微生物群和阿片类药物耐受性之间的双向关系.
- 讨论调节肠道微生物组作为治疗策略的潜力.
- 确定研究和临床干预机会.
主要方法:
- 对调查肠道微生物组和阿片类药物相互作用的研究进行文献综述.
- 分析阿片类药物对肠道微生物组成 (失调) 的影响.
- 检查肠道微生物组的变化如何影响阿片类药物的有效性和耐受性.
主要成果:
- 阿片类药物诱导肠道失调,创造一个积极的反循环,加剧阿片类药物耐受性.
- 肠道微生物组合的变化直接影响了阿片类药物耐受性的发展和严重程度.
- 肠道微生物组和阿片类药物耐受性之间的关系是双向的.
结论:
- 肠道微生物组是阿片类药物耐受性和持续的阿片类药物危机的一个关键因素.
- 调节肠道微生物组为管理阿片类药物耐受性和阿片类药物使用障碍提供了一个有希望的治疗途径.
- 需要进一步的研究来将这些发现转化为阿片类药物诱导的肠道失调症的临床干预措施.
更多相关视频
相关概念视频
Analgesia and Pain Management
634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
214
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
214
Opioid Analgesics: Morphine and Other Natural Cogeners
262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Opioid Receptors: Overview
932
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
932
Opioid Analgesics: Synthetic and Semisynthetic Opioids
310
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
310
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186


